Weiss Eric Stanton 4
4 · Core Scientific, Inc./tx · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Core Scientific Director Eric Weiss Receives 18,575 RSUs
What Happened
Weiss Eric Stanton (director) was granted 18,575 restricted stock units (RSUs) by Core Scientific (CORZ) on February 4, 2026. The grant price reported is $0.00 (an award rather than a purchase), so there was no cash exchanged at grant.
Key Details
- Transaction type: Award/Grant (code A) of RSUs.
- Transaction date: 2026-02-04; filing date: 2026-02-06 (appears timely).
- Shares/units granted: 18,575 RSUs; reported acquisition price: $0.00 (value at grant not listed).
- Vesting: RSUs will vest in full on February 3, 2027, provided Mr. Weiss continues as a non-employee director (per filing footnote).
- Shares owned after transaction: Not disclosed in this Form 4 filing.
- No indication of a 10b5-1 plan, tax withholding, or immediate sale in this filing.
Context
RSU grants to non-employee directors are common compensation for board service; they vest later and do not represent an immediate purchase or sale of stock. Such awards are informational about compensation but do not alone signal an executive buying or selling shares for personal investment.
Insider Transaction Report
Form 4
Weiss Eric Stanton
Director
Transactions
- Award
Common Stock
[F1]2026-02-04+18,575→ 245,262 total
Footnotes (1)
- [F1]Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on February 3, 2027, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date.
Signature
/s/ Todd DuChene, as Attorney-in-Fact|2026-02-06